Sino Medical: Subsidiary's intracranial thrombectomy stent has obtained registration approval in Turkey.

Sino Medical announced that its holding subsidiary, Sino Shenchang, has recently received registration approval from the Turkish Ministry of Health for the Ghunter Revascularization Device, an intracranial thrombectomy stent independently developed by the company. This product is designed to remove thrombus from large intracranial blood vessels in patients with ischemic stroke, restoring blood flow. It received its registration certificate from the National Medical Products Administration in April 2023 and obtained EU CEMDR certification in February 2026. This approval marks the first time that a product from Sino Shenchang has passed the registration application in Turkey, which will positively impact the promotion and sales of the company's products in the corresponding market. However, the specific impact on performance remains unpredictable due to factors such as regulatory policies, market conditions, and exchange rate fluctuations.